Cleavage of the HER2 ectodomain is a pervanadate-activable process that is inhibited by the tissue inhibitor of metalloproteases-1 in breast cancer cells.
1999 · PubMed · 238 citations
J
Juan Carlos López-Talavera
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
52
Papers
3.9K
Citations
28
h-index
30
i10-index
Juan Carlos López-Talavera is an academic researcher from OncoGenex Pharmaceuticals (United States). The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Hepatitis C virus research & Liver Disease and Transplantation. The author has an h-index of 28, co-authored 45 publications.
Papers by this author
worksCorrigendum to: “Endoscopic duodenal mucosal resurfacing improves glycaemic and hepatic indices in type 2 diabetes: 6-month multicentre results” [JHEP Reports 5 (2019) 101041]
2024 · JHEP Reports · 1 citations
https://doi.org/10.1016/j.jhepr.2024.101041
WED-220 BOS-580, a long-acting FGF-21 analogue, treatment shows beneficial changes in the circulating lipidome and improves MASEF score in patients with phenotypic metabolic dysfunction-associated steatohepatitis in a phase 2a randomized, placebo-controlled, 12-week study
2024 · Journal of Hepatology · 0 citations
https://doi.org/10.1016/s0168-8278(24)01561-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat